1. Home
  2. SLI vs PHAT Comparison

SLI vs PHAT Comparison

Compare SLI & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard Lithium Ltd.

SLI

Standard Lithium Ltd.

HOLD

Current Price

$2.29

Market Cap

906.4M

Sector

Industrials

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$10.92

Market Cap

969.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLI
PHAT
Founded
1998
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.4M
969.8M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
SLI
PHAT
Price
$2.29
$10.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$5.25
$19.83
AVG Volume (30 Days)
1.9M
1.2M
Earning Date
05-11-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.72
EPS
N/A
N/A
Revenue
N/A
$175,110,000.00
Revenue This Year
N/A
$93.04
Revenue Next Year
N/A
$58.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
216.93
52 Week Low
$2.20
$7.61
52 Week High
$6.40
$18.31

Technical Indicators

Market Signals
Indicator
SLI
PHAT
Relative Strength Index (RSI) 24.12 48.04
Support Level N/A $10.02
Resistance Level $4.38 $11.65
Average True Range (ATR) 0.15 0.71
MACD -0.03 0.01
Stochastic Oscillator 8.60 34.40

Price Performance

Historical Comparison
SLI
PHAT

About SLI Standard Lithium Ltd.

Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company the company's flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. It is also Standard Lithium is advancing the South West Arkansas project, a greenfield project located in southern Arkansas, and strengthening lithium brine prospects in East Texas. Its other project comprises the Lanxess Property Project; and California Properties. The technologies used for the projects are : Direct Lithium Extraction; Demonstration Plant; SiFT; Lithium Sulfide; and Aqualung.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: